Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 32Eli Lilly

02 1ORIFARM GROUP AS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 2.5MG/0.5ML (2.5MG/0.5ML)

Packaging :

Approval Date : 2022-05-13

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

02

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 5MG/0.5ML (5MG/0.5ML)

Packaging :

Approval Date : 2022-05-13

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

03

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 7.5MG/0.5ML (7.5MG/0.5ML)

Packaging :

Approval Date : 2022-05-13

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

04

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 10MG/0.5ML (10MG/0.5ML)

Packaging :

Approval Date : 2022-05-13

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

05

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 12.5MG/0.5ML (12.5MG/0.5ML)

Packaging :

Approval Date : 2022-05-13

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

06

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 15MG/0.5ML (15MG/0.5ML)

Packaging :

Approval Date : 2022-05-13

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

07

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 2.5MG/0.5ML (2.5MG/0.5ML)

Packaging :

Approval Date : 2023-07-28

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

08

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 5MG/0.5ML (5MG/0.5ML)

Packaging :

Approval Date : 2023-07-28

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

09

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 7.5MG/0.5ML (7.5MG/0.5ML)

Packaging :

Approval Date : 2023-07-28

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

10

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 10MG/0.5ML (10MG/0.5ML)

Packaging :

Approval Date : 2023-07-28

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

11

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 12.5MG/0.5ML (12.5MG/0.5ML)

Packaging :

Approval Date : 2023-07-28

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

12

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 15MG/0.5ML (15MG/0.5ML)

Packaging :

Approval Date : 2023-07-28

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

13

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 2.5MG/0.5ML (2.5MG/0.5ML)

Packaging :

Approval Date : 2023-11-08

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

14

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 5MG/0.5ML (5MG/0.5ML)

Packaging :

Approval Date : 2023-11-08

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

15

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 7.5MG/0.5ML (7.5MG/0.5ML)

Packaging :

Approval Date : 2023-11-08

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

16

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 10MG/0.5ML (10MG/0.5ML)

Packaging :

Approval Date : 2023-11-08

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

17

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 12.5MG/0.5ML (12.5MG/0.5ML)

Packaging :

Approval Date : 2023-11-08

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

18

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 15MG/0.5ML (15MG/0.5ML)

Packaging :

Approval Date : 2023-11-08

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

19

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 2.5MG/0.5ML (2.5MG/0.5ML)

Packaging :

Approval Date : 2024-03-28

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

20

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 5MG/0.5ML (5MG/0.5ML)

Packaging :

Approval Date : 2024-03-28

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

21

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 7.5MG/0.5ML (7.5MG/0.5ML)

Packaging :

Approval Date : 2024-03-28

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

22

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 10MG/0.5ML (10MG/0.5ML)

Packaging :

Approval Date : 2024-03-28

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

23

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 12.5MG/0.5ML (12.5MG/0.5ML)

Packaging :

Approval Date : 2024-03-28

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

24

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 15MG/0.5ML (15MG/0.5ML)

Packaging :

Approval Date : 2024-03-28

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

25

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

Tirzepatid

Brand Name : Mounjaro

Dosage Form : Solution for injection in a pre-filled pen

Dosage Strength : 2.5 mg

Packaging : Pre-filled pen 4 0.5ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

26

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

Tirzepatid

Brand Name : Mounjaro

Dosage Form : Solution for injection in a pre-filled pen

Dosage Strength : 5 mg

Packaging : Pre-filled pen 4 0.5ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

27

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO

Dosage Form : SOLUTION

Dosage Strength : 2.5MG/0.5ML

Packaging :

Approval Date :

Application Number : 2541041

Regulatory Info : Prescription

Registration Country : Canada

blank

28

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO

Dosage Form : SOLUTION

Dosage Strength : 5MG/0.5ML

Packaging :

Approval Date :

Application Number : 2541068

Regulatory Info : Prescription

Registration Country : Canada

blank

29

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO

Dosage Form : SOLUTION

Dosage Strength : 7.5MG/0.5ML

Packaging :

Approval Date :

Application Number : 2541076

Regulatory Info : Prescription

Registration Country : Canada

blank

30

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

Tirzepatid

Brand Name : Mounjaro

Dosage Form : Solution for injection

Dosage Strength : 2.5 mg

Packaging : Vials 1 0.5ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank